15.04.2011 • NewsCarbon BlackCVC Capital PartnersEvonik

Rhone to Buy Carbon Black for €900 Million

Financial investor Rhone Group is close to a deal to buy the Carbon Black unit of unlisted German chemical maker Evonik, a source close to the deal said on Thursday.

The sale is expected to fetch just over €900 million ($1.3 billion), and could be signed as soon as Friday, the person said. Evonik declined to comment.

Carbon Black was originally derived from soot, and more than 60% of world's production is used to make tyres more durable. It is also used for laser printers and photocopier toners.

Market researcher Freedonia expects the global Carbon Black market to rise 4.3% per year until 2013, driven mainly by tyre demand in Asia.

Evonik, which said last year that it has hired an investment bank to manage the sale of the unit, has said it plans to use the proceeds to expand its core specialty chemicals business.

Evonik is majority owned by a government-controlled trust that bears the long-term liabilities of Germany's wound-down coal mining industry.

Private equity firm CVC Capital Partners bought a 25% stake in Evonik in 2008.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.